Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/05/2023 | Neoleukin Therapeutics, Inc. | AQXP | Exercise (in-the-money or at-the-money) | Pre-funded Warrants | 57k | $0.00 | $0 | See Footnotes | 10/05/2023 |
10/05/2023 | Neoleukin Therapeutics, Inc. | AQXP | Exercise (in-the-money or at-the-money) | Pre-funded Warrants | 535.6k | $0.00 | $0 | See Footnotes | 10/05/2023 |
10/03/2023 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Purchase | Common Stock Warrant (right to buy) | 125.4k | $0.00 | $12.5 | See Footnotes | 10/03/2023 |
10/03/2023 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Purchase | Common Stock Warrant (right to buy) | 1.5M | $0.00 | $152.3 | See Footnotes | 10/03/2023 |
09/29/2023 | IGM Biosciences, Inc. | IGMS | Grant | Common Stock | 554 | $0.00 | $0 | See Footnotes | 09/29/2023 |
09/29/2023 | INCYTE CORP | INCY | Grant | Common Stock | 510 | $0.00 | $0 | See Footnotes | 09/29/2023 |
08/17/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 7.7k | $0.69 | $5.3k | See Footnotes | 08/15/2023 |
08/17/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 93.1k | $0.69 | $64.5k | See Footnotes | 08/15/2023 |
08/17/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 5k | $0.69 | $3.5k | See Footnotes | 08/15/2023 |
08/17/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 61.1k | $0.69 | $42.4k | See Footnotes | 08/15/2023 |
08/16/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 17.1k | $0.68 | $11.7k | See Footnotes | 08/15/2023 |
08/16/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 207.7k | $0.68 | $141.3k | See Footnotes | 08/15/2023 |
08/16/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 366 | $0.68 | $249.9 | See Footnotes | 08/15/2023 |
08/16/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 4.4k | $0.68 | $3k | See Footnotes | 08/15/2023 |
08/15/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 143.5k | $0.63 | $90.5k | See Footnotes | 08/15/2023 |
08/15/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 1.7M | $0.63 | $1.1M | See Footnotes | 08/15/2023 |
08/15/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 358 | $0.67 | $238.1 | See Footnotes | 08/15/2023 |
08/15/2023 | Neoleukin Therapeutics, Inc. | AQXP | Purchase | Common Stock | 4.3k | $0.67 | $2.9k | See Footnotes | 08/15/2023 |
06/30/2023 | Kodiak Sciences Inc. | KOD | Grant | Non-Qualified Stock Options (right to buy) | 40k | $6.90 | $276k | See Footnotes | 06/30/2023 |
06/30/2023 | IGM Biosciences, Inc. | IGMS | Grant | Common Stock | 554 | $0.00 | $0 | See Footnotes | 06/30/2023 |
06/30/2023 | INCYTE CORP | INCY | Grant | Common Stock | 512 | $0.00 | $0 | See Footnotes | 06/30/2023 |
06/26/2023 | IGM Biosciences, Inc. | IGMS | Purchase | Non-Voting Common Stock | 5.2M | $8.00 | $41.7M | See Footnotes | 06/26/2023 |
06/26/2023 | IGM Biosciences, Inc. | IGMS | Purchase | Non-Voting Common Stock | 413.2k | $8.00 | $3.3M | See Footnotes | 06/26/2023 |
06/14/2023 | INCYTE CORP | INCY | Grant | Non- Qualified Stock Option (right to buy) | 11.3k | $61.44 | $693.9k | See Footnotes | 06/14/2023 |
06/14/2023 | INCYTE CORP | INCY | Grant | Non- Qualified Stock Option (right to buy) | 11.3k | $61.44 | $693.9k | See Footnotes | 06/14/2023 |
06/14/2023 | INCYTE CORP | INCY | Grant | Common Stock | 2.5k | $0.00 | $0 | See Footnotes | 06/14/2023 |
06/08/2023 | Neoleukin Therapeutics, Inc. | AQXP | Grant | Non-Qualified Stock Option (right to buy) | 25k | $0.79 | $19.8k | See Footnotes | 06/08/2023 |
06/06/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Non-Qualified Share Option (right to buy) | 52.5k | $15.19 | $797k | See Footnotes | 06/06/2023 |
06/06/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Class A Common Shares | 8.7k | $0.00 | $0 | See Footnotes | 06/06/2023 |
06/06/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Non-Qualified Share Option (right to buy) | 52.5k | $15.19 | $797k | See Footnotes | 06/06/2023 |
06/01/2023 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Common Stock | 13.3k | $0.00 | $0 | See Footnotes | 06/01/2023 |
06/01/2023 | ACADIA PHARMACEUTICALS INC | ACAD | Grant | Non-Qualified Stock Options (right to buy) | 22.1k | $23.90 | $528k | See Footnotes | 06/01/2023 |
05/31/2023 | Seagen Inc. | SGEN | Grant | Common Stock | 2k | $0.00 | $0 | See footnotes | 05/31/2023 |
05/31/2023 | Seagen Inc. | SGEN | Grant | Common Stock | 2k | $0.00 | $0 | See footnotes | 05/31/2023 |
05/24/2023 | ACADIA PHARMACEUTICALS INC | ACAD | Purchase | Common Stock | 20.3k | $25.27 | $513.1k | See Footnotes | 05/22/2023 |
|